Charmaine Hall RBT

Recommended Articles

• Childhood Crohn’s Diagnosis Linked with Cancer Risk, Study Finds

  Inflammatory bowel disease most often affects young adults. However, children can also be diagnosed too. When inflammatory bowel disease affects a child, it causes painful gastrointestinal symptoms that are especially difficult for kids to bear.It's hard for kids to understand what's happening to...

• Low Serotonin Levels May Be Linked to Development of Alzheimer's

  As the future becomes the present then the past, scientists, doctors, and patients alike learn more and more about Alzheimer’s disease and how it develops.Today, researchers are learning about the role serotonin plays in the progression of this disease. While the causes of Alzheimer’s are not...

• Toxin Exposure During Late Pregnancy Is Correlated with Autism

  We do not entirely understand the various causes of autism. For some things, we have a good idea, and others, we are still learning. Some factors are environmental. Other factors are known to be genetic.One of the newer developments is the knowledge that toxins ingested in the later part of...

• Are There Health Benefits of Cilantro?

  What is cilantro and where does it come from?Cilantro is a plant that blooms and is replanted yearly. Thus, it is considered an annual herb. Its scientific name is Coriandrum sativum and is also known as "coriander" or "Chinese parsley". Every part of the plant is edible, but its dried seeds and...

• Lena Dunham Opens Up About Fibromyalgia Diagnosis

  Fibromyalgia involves widespread pain throughout the patient's entire body. For some, the pain might only be in specific areas, like the back and neck. Those with fibromyalgia also have extreme sensitivity, stiffness, and bone-wearing fatigue. ...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...